A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

Summary

The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis

Timeline

Start

—

Primary completion

—

Completion

—

Publications

• Background New CMV drug won't replace other therapies. AIDS Alert. 1998 Nov;13(11):124-6.
• Background Roehr B. Fomivirsen approved for CMV retinitis. J Int Assoc Physicians AIDS Care. 1998 Oct;4(10):14-6.

Drugs

Indications